Overview

Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid.

Status:
Completed

Trial end date:
2019-04-11

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the safety and efficacy of GKT13783 in patients with Primary Biliary Cholangitis (PBC) who are taking a stable dose of ursodeoxycholic acid (UDCA) treatment, and have persistently high levels of a liver enzyme called Alkaline Phosphatase (ALP).

Phase:

Phase 2

Details

Lead Sponsor:

Genkyotex SA

Treatments:

Ursodeoxycholic Acid